Solvay moves into medical devices launching a unique dental care business line
21 Mars 2017 - 7:30AM
Brussels, March 21, 2017 ---
Solvay is entering into medical devices building on its
world-leading portfolio of high-performance polymers with a new
dental care business line. "Solvay Dental 360(TM)" spans from an
innovative material to replace metal in removable partial denture
frames, to enabling a digital workflow that accelerates the work of
dental laboratories and dentists.
Removable partial denture (RPD)
frames replace missing teeth and are typically made of metal. Under
Solvay Dental 360(TM), Solvay's new high-performance material
allows for metal-free, biocompatible, more comfortable,
natural-looking RPD frames which are over 60% lighter than a metal
frame.
Solvay uses its new Ultaire(TM)
AKP (aryl ketone polymer) material to make its Dentivera(TM)
milling disc. From this device, trained and qualified dental lab
technicians use software tailored to this material to design and
mill the RPD frame. This enhances speed and efficiency as fewer
manufacturing steps are needed compared to the metal frame.
"Solvay's
entrepreneurial initiative to launch into medical devices is driven
by our innovation power as a world leader in metal-replacing
materials and their proven track record in healthcare," said
Jean-Pierre Clamadieu, CEO of Solvay.
"Solvay proudly
starts off in dental care devices with a unique full-circle
offering that increases the comfort of patients and efficiency for
dentists and lab technicians," said Shawn Shorrock, Global
Director Solvay Dental 360(TM).
Solvay's unrivalled portfolio of
high-performance polymers cover over 35 brands in more than 1,500
formulations. In healthcare, they are used in orthopedic,
cardiovascular, renal and other markets.
The Dentivera(TM) milling disc is
approved by the EU and U.S. health regulators. The launch of Solvay
Dental 360(TM) takes place at the 2017 International Dental Show
(IDS) in Cologne, Germany.
For more information about Solvay
Dental 360(TM), Ultaire(TM) AKP and Dentivera(TM) milling discs,
please visit www.solvaydental360.com.
Follow us on twitter
@SolvayGroup
Solvay is a multi-specialty
chemical company, committed to developing chemistry that addresses
key societal challenges. Solvay innovates and partners with
customers in diverse global end markets. Its products and solutions
are used in planes, cars, smart and medical devices, batteries, in
mineral and oil extraction, among many other applications promoting
sustainability. Its lightweighting materials enhance cleaner
mobility, its formulations optimize the use of resources and its
performance chemicals improve air and water quality. Solvay is
headquartered in Brussels with around 27,000 employees in 58
countries. Pro forma net sales were € 10.9 billion in
2016, with 90% from activities where Solvay ranks among the world's
top 3 leaders. Solvay SA (SOLB.BE) is listed on Euronext
Brussels and Paris (Bloomberg: SOLB.BB -
Reuters: SOLB.BR) and in the United States its shares (SOLVY)
are traded through a level-1 ADR program. |
Caroline Jacobs |
Kimberly Stewart |
Jodi Allen |
Geoffroy Raskin |
Bisser Alexandrov |
Media Relations |
Investor Relations |
Investor Relations |
Investor Relations |
Investor Relations |
+32 2 264 1530 |
+32 2 264 3694 |
+1 9733573283 |
+32 2 264 1540 |
+32 2 264 3687 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
To read this release in
PDF
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Solvay S.A. via Globenewswire
Solvay (EU:SOLB)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Solvay (EU:SOLB)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024